Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06519123 · ClinicalTrials.gov registry record · NA
Ambient Digital Scribes Populating Clinical Notes
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 261
- Enrollment target
NCT06519123: Completed NA study, sponsored by Duke University.
NCT06519123 is a NA study that has completed, run by Duke University. The registered enrollment target is 261 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06519123, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 261 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of Ambient Digital Scribes that will automatically record clinical encounters and use AI technology to populate clinical notes. The investigators expect that when clinicians do not need to either write notes during the clinical encounter and can instead face patients when talking, several effects could result, including 1) patients report higher satisfaction with the visit 2) clinicians report less burnout, and 3) clinician-patient communication includes more evidence-based tools that indicate high quality communication.
Primary Outcome
Patient perceived empathy will be assessed via post doctor appointment administered survey.
Interventions
- OTHER Ambient Digital Scribes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2024-09-19 |
| Est. Completion | 2025-01-30 |
| Phase | NA |
What the finished NCT06519123 record still lists
NCT06519123 is an interventional study that assigns participants to a tested intervention. The registered 261 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Ambient Digital Scribes is the first listed.
NCT06519123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06519123 about?
NCT06519123 is a clinical study titled "Ambient Digital Scribes Populating Clinical Notes". The purpose of this study is to assess the impact of Ambient Digital Scribes that will automatically record clinical encounters and use AI technology to populate clinical notes. The investigators expect that when clinicians do not need to either write notes during the clinical encounter and can inst...
What is the current status of trial NCT06519123?
This trial is currently completed. It is a NA study. The enrollment target is 261 participants. The study started on 2024-09-19. Estimated completion is 2025-01-30.
What interventions are being tested in trial NCT06519123?
The interventions under investigation include: Ambient Digital Scribes (OTHER).
Who is sponsoring clinical trial NCT06519123?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06519123's enrollment target sits among peer trials
261 397th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05124912 · 261 participants · NA
REMASTer: REcurrent Brain Metastases After SRS Trial
- NCT06559891 · 261 participants · NA
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI